Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts PRAX Hot Sheet
Join SI Premium – FREE
Praxis Precision Medicines (NASDAQ: PRAX) reported Q3 EPS of ($3.36), $0.11 better than the analyst estimate of ($3.47).
For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Starts PPG Industries (PPG) at Overweight
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- KeyBanc Starts FMC Corp. (FMC) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
